Growth promoting substrates for human dermal fibroblasts provided by artificial extracellular matrices composed of collagen I and sulfated glycosaminoglycans

Biomaterials

Volumn 32, Issue 34, 2011, Pages 8938-8946

  van der Smissen, Anja ^a,d   Hintze, Vera ^b,d   Scharnweber, Dieter ^b,d   Moeller, Stephanie ^c,d   Schnabelrauch, Matthias ^c,d   Majok, Annett ^a,d   Simon, Jan C ^a,d   Anderegg, Ulf ^a,d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Biomaterials Department   (Germany)

^d Matrixengineering Leipzig and Dresden ^*  (Germany)

Author keywords

Chondroitin sulfate; Collagen I; Human dermal fibroblasts; Hyaluronan; Sulfated glycosaminoglycan; Wound healing

Indexed keywords

CHONDROITIN SULFATES; COLLAGEN I; GLYCOSAMINOGLYCANS; HUMAN DERMAL FIBROBLASTS; HYALURONAN; WOUND HEALING;

BIOACTIVITY; BIOLOGICAL MATERIALS; BIOMATERIALS; CELL CULTURE; CELL PROLIFERATION; COLLAGEN; FIBROBLASTS;

ADHESION;

ALPHA SMOOTH MUSCLE ACTIN; CHONDROITIN SULFATE; COLLAGEN TYPE 1; GLYCOSAMINOGLYCAN POLYSULFATE; GROWTH FACTOR; HYALURONIC ACID; INTERSTITIAL COLLAGENASE;

ARTICLE; ARTIFICIAL EXTRACELLULAR MATRIX; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL MODIFICATION; CYTOLOGY; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; WESTERN BLOTTING; WOUND HEALING;

BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROITIN SULFATES; COLLAGEN TYPE I; DERMIS; FIBROBLASTS; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; WOUND HEALING;

EID: 80053092014     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.025     Document Type: Article

References (55)

1. Clark R.A., Ghosh K., Tonnesen M.G. Tissue engineering for cutaneous wounds. J Invest Dermatol 2007, 127:1018-1029.
2. Dieckmann C., Renner R., Milkova L., Simon J.C. Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond. Exp Dermatol 2010, 19:697-706.
3. Hackam D.J., Ford H.R. Cellular, biochemical, and clinical aspects of wound healing. Surg Infect (Larchmt) 2002, 3(Suppl 1):S23-S35.
4. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870.
5. Werner S., Krieg T., Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 2007, 127:998-1008.
6. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363.
7. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007, 127:526-537.
8. Kirchhofer D., Languino L.R., Ruoslahti E., Pierschbacher M.D. Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem 1990, 265:615-618.
9. Langholz O., Rockel D., Mauch C., Kozlowska E., Bank I., Krieg T., et al. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 1995, 131:1903-1915.
10. Wayner E.A., Carter W.G. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol 1987, 105:1873-1884.
11. Clark R.A., Lin F., Greiling D., An J., Couchman J.R. Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan. J Invest Dermatol 2004, 122:266-277.
12. Jackson D.G. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 2003, 13:1-7.
13. Toole B.P. Hyaluronan in morphogenesis. Semin Cell Dev Biol 2001, 12:79-87.
14. Eckes B., Nischt R., Krieg T. Cell-matrix interactions in dermal repair and scarring. Fibrogenesis Tissue Repair 2010, 3:4.
15. Lavenus S., Pilet P., Guicheux J., Weiss P., Louarn G., Layrolle P. Behaviour of mesenchymal stem cells, fibroblasts and osteoblasts on smooth surfaces. Acta Biomater 2011, 7:1525-1534.
16. Wipff P.J., Rifkin D.B., Meister J.J., Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007, 179:1311-1323.
17. Eckes B., Zweers M.C., Zhang Z.G., Hallinger R., Mauch C., Aumailley M., et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J Investig Dermatol Symp Proc 2006, 11:66-72.
18. Kunze R., Rosler M., Moller S., Schnabelrauch M., Riemer T., Hempel U., et al. Sulfated hyaluronan derivatives reduce the proliferation rate of primary rat calvarial osteoblasts. Glycoconj J 2010, 27:151-158.
19. Schiller J., Becher J., Moller S., Nimptsch K., Riemer T., Schnabelrauch M. Synthesis and characterization of chemically modified hyaluronan and chondroitin sulfate. Mini-Reviews Org Chem 2010, 7:290-299.
20. Hintze V., Moeller S., Schnabelrauch M., Bierbaum S., Viola M., Worch H., et al. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4). Biomacromolecules 2009, 10:3290-3297.
21. Sasisekharan R., Raman R., Prabhakar V. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng 2006, 8:181-231.
22. Gandhi N.S., Mancera R.L. The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 2008, 72:455-482.
23. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
24. Salek-Ardakani S., Arrand J.R., Shaw D., Mackett M. Heparin and heparan sulfate bind interleukin-10 and modulate its activity. Blood 2000, 96:1879-1888.
25. Gama C.I., Tully S.E., Sotogaku N., Clark P.M., Rawat M., Vaidehi N., et al. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat Chem Biol 2006, 2:467-473.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
27. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177.
28. Balazs E.A., Berntsen K.O., Karossa J., Swann D.A. An automated method for the determination of hexosamines. Anal Biochem 1965, 12:559-564.
29. Saalbach A., Klein C., Schirmer C., Briest W., Anderegg U., Simon J.C. Dermal fibroblasts promote the migration of dendritic cells. J Invest Dermatol 2010, 130:444-454.
30. Vincent S., Marty L., Fort P. S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res 1993, 21:1498.
31. Steele J.G., Johnson G., Underwood P.A. Role of serum vitronectin and fibronectin in adhesion of fibroblasts following seeding onto tissue culture polystyrene. J Biomed Mater Res 1992, 26:861-884.
32. Croce M.A., Boraldi F., Quaglino D., Tiozzo R., Pasquali-Ronchetti I. Hyaluronan uptake by adult human skin fibroblasts in vitro. Eur J Histochem 2003, 47:63-73.
33. David-Raoudi M., Tranchepain F., Deschrevel B., Vincent J.C., Bogdanowicz P., Boumediene K., et al. Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair Regen 2008, 16:274-287.
34. Huang L., Gu H., Burd A. A reappraisal of the biological effects of hyaluronan on human dermal fibroblast. J Biomed Mater Res A 2009, 90:1177-1185.
35. Clark R.A. Cutaneous tissue repair: basic biologic considerations. J Am Acad Dermatol 1985, 13:701-725.
36. Jacobson A., Brinck J., Briskin M.J., Spicer A.P., Heldin P. Expression of human hyaluronan synthases in response to external stimuli. Biochem J 2000, 348(1):29-35.
37. Li L., Asteriou T., Bernert B., Heldin C.H., Heldin P. Growth factor regulation of hyaluronan synthesis and degradation in human dermal fibroblasts: importance of hyaluronan for the mitogenic response of PDGF-BB. Biochem J 2007, 404:327-336.
38. Hinz B., Mastrangelo D., Iselin C.E., Chaponnier C., Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001, 159:1009-1020.
39. Williams D.F. On the nature of biomaterials. Biomaterials 2009, 30:5897-5909.
40. Larsen M., Artym V.V., Green J.A., Yamada K.M. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 2006, 18:463-471.
41. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
42. Lee J.O., Rieu P., Arnaout M.A., Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 1995, 80:631-638.
43. Vorup-Jensen T., Chi L., Gjelstrup L.C., Jensen U.B., Jewett C.A., Xie C., et al. Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin. J Biol Chem 2007, 282:30869-30877.
44. Yampolskaya G., Platikanov D. Proteins at fluid interfaces: adsorption layers and thin liquid films. Adv Colloid Interface Sci 2006, 128-130:159-183.
45. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
46. Wang C.C., Lu J.N., Young T.H. The alteration of cell membrane charge after cultured on polymer membranes. Biomaterials 2007, 28:625-631.
47. Gariboldi S., Palazzo M., Zanobbio L., Selleri S., Sommariva M., Sfondrini L., et al. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol 2008, 181:2103-2110.
48. Termeer C.C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000, 165:1863-1870.
49. Tesar B.M., Jiang D., Liang J., Palmer S.M., Noble P.W., Goldstein D.R. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 2006, 6:2622-2635.
50. Taylor K.R., Yamasaki K., Radek K.A., Di N.A., Goodarzi H., Golenbock D., et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2. J Biol Chem 2007, 282:18265-18275.
51. Yamawaki H., Hirohata S., Miyoshi T., Takahashi K., Ogawa H., Shinohata R., et al. Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology 2009, 19:83-92.
52. Nolte S.V., Xu W., Rennekampff H.O., Rodemann H.P. Diversity of fibroblasts-a review on implications for skin tissue engineering. Cells Tissues Organs 2008, 187:165-176.
53. Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997, 242:27-33.
54. Subramaniam K., Pech C.M., Stacey M.C., Wallace H.J. Induction of MMP-1, MMP-3 and TIMP-1 in normal dermal fibroblasts by chronic venous leg ulcer wound fluid*. Int Wound J 2008, 5:79-86.
55. Averbeck M., Gebhardt C.A., Voigt S., Beilharz S., Anderegg U., Termeer C.C., et al. Differential regulation of hyaluronan metabolism in the epidermal and dermal compartments of human skin by UVB irradiation. J Invest Dermatol 2007, 127:687-697.